- Home
- CHEK vs PALI Comparison
CHEK vs PALI Comparison
Compare CHEK & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- PALI
- Stock Information
- Founded
- CHEK 2004
- PALI 1996
- Country
- CHEK Israel
- PALI United States
- Employees
- CHEK N/A
- PALI N/A
- Industry
- CHEK Medical Electronics
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHEK Health Care
- PALI Health Care
- Exchange
- CHEK Nasdaq
- PALI Nasdaq
- Market Cap
- CHEK 4.5M
- PALI 5.0M
- IPO Year
- CHEK 2015
- PALI N/A
- Fundamental
- Price
- CHEK $0.67
- PALI $0.81
- Analyst Decision
- CHEK
- PALI Strong Buy
- Analyst Count
- CHEK 0
- PALI 2
- Target Price
- CHEK N/A
- PALI $12.00
- AVG Volume (30 Days)
- CHEK 26.5K
- PALI 6.2M
- Earning Date
- CHEK 08-26-2025
- PALI 08-11-2025
- Dividend Yield
- CHEK N/A
- PALI N/A
- EPS Growth
- CHEK N/A
- PALI N/A
- EPS
- CHEK N/A
- PALI N/A
- Revenue
- CHEK N/A
- PALI N/A
- Revenue This Year
- CHEK N/A
- PALI N/A
- Revenue Next Year
- CHEK N/A
- PALI N/A
- P/E Ratio
- CHEK N/A
- PALI N/A
- Revenue Growth
- CHEK N/A
- PALI N/A
- 52 Week Low
- CHEK $0.56
- PALI $0.60
- 52 Week High
- CHEK $3.04
- PALI $4.32
- Technical
- Relative Strength Index (RSI)
- CHEK 40.79
- PALI 44.16
- Support Level
- CHEK $0.59
- PALI $0.66
- Resistance Level
- CHEK $0.68
- PALI $1.90
- Average True Range (ATR)
- CHEK 0.04
- PALI 0.17
- MACD
- CHEK 0.00
- PALI -0.03
- Stochastic Oscillator
- CHEK 46.45
- PALI 11.37
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.